HIV

Cervical Cancer Drugs: Industry Trends and Opportunity Forecast, 2026 - ResearchAndMarkets.com

Retrieved on: 
Monday, August 15, 2022 - 4:02pm

The "Cervical Cancer Drugs Global Market Report 2022, Cancer Type, Drug Type, Distribution Channel" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Cervical Cancer Drugs Global Market Report 2022, Cancer Type, Drug Type, Distribution Channel" report has been added to ResearchAndMarkets.com's offering.
  • North America is the largest region in the cervical cancer drugs market in 2021.
  • The increasing prevalence of HIV (Human immunodeficiency virus) in women is driving the growth of the cervical cancer drugs market.
  • The lack of awareness and other misconceptions about cervical cancers hinder the growth of the cervical cancer drugs market.

ADAP Advocacy Association Spearheads National Campaign to Protect Ryan White HIV/AIDS Program

Retrieved on: 
Monday, August 15, 2022 - 12:07pm

WASHINGTON, Aug. 15, 2022 /PRNewswire/ -- The ADAP Advocacy Association today submitted a sign-on letter to Congress expressing the HIV Community's collective concerns over the Ryan White PrEP Availability Act (S.4395). The sign-on letter – which was endorsed by nearly 100 national, state, and local organizations – is part of a national campaign to protect the Ryan White HIV/AIDS Program (RWHAP), namely opposing efforts to raid the program to fund pre-exposure prophylaxis.

Key Points: 
  • WASHINGTON, Aug. 15, 2022 /PRNewswire/ -- The ADAP Advocacy Association today submitted a sign-on letter to Congress expressing the HIV Community's collective concerns over the Ryan White PrEP Availability Act (S.4395).
  • The sign-on letter which was endorsed by nearly 100 national, state, and local organizations is part of a national campaign to protect the Ryan White HIV/AIDS Program (RWHAP), namely opposing efforts to raid the program to fund pre-exposure prophylaxis.
  • To learn more about the ADAP Advocacy Association , AIDS Drug Assistance Programs, or S.4395, please email info@adapadvocacy.org.
  • About the ADAP Advocacy Association: The ADAP Advocacy Association mission is to promote and enhance the AIDS Drug Assistance Programs (ADAPs) and improves access to care for persons living with HIV/AIDS.

Guillaume Laverdure appointed CEO of Medicom Group

Retrieved on: 
Monday, August 15, 2022 - 11:00am

POINTE-CLAIRE, QC, Aug. 15, 2022 /PRNewswire/ - Canada-based Medicom Group ("Medicom"), a world leader in the production and distribution of infection prevention and control solutions, is pleased to announce the appointment of Guillaume Laverdure as CEO.

Key Points: 
  • POINTE-CLAIRE, QC, Aug. 15, 2022 /PRNewswire/ - Canada-based Medicom Group ("Medicom"), a world leader in the production and distribution of infection prevention and control solutions, is pleased to announce the appointment of Guillaume Laverdure as CEO.
  • Mr. Laverdure has most recently held the position of Chief Operating Officer within the Group.
  • It is with this same mission to live up to our pride in protection that I begin my new mandate," said Guillaume Laverdure, Medicom's new CEO.
  • Today, the Medicom Group distributes infection control products under the Medicom, Ritmed, Kolmi, Hopen, Ocean Pacific and Hedy brands.

Enochian Biosciences Inc. Shareholder Notice: Robbins LLP Reminds Investors of Lead Plaintiff Deadline in Class Action Against Enochian Biosciences Inc. (ENOB)

Retrieved on: 
Friday, August 12, 2022 - 8:36pm

If you would like more information about Enochian Biosciences Inc.'s misconduct, click here .

Key Points: 
  • If you would like more information about Enochian Biosciences Inc.'s misconduct, click here .
  • On May 25, 2022, the U.S. Department of Justice announced that Gumrukcu had been arrested and charged in a murder-for-hire conspiracy.
  • On this news, the price of Enochian's stock fell almost 37%, to close at $3.70 per share on May 25, 2022.
  • A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

Fujifilm and Qure.ai Join Hands With IHVN to Accelerate TB Screening in Rural Nigerian Communities

Retrieved on: 
Friday, August 12, 2022 - 9:07am

The partnership has enabled USAID funded IHVN to deploy ultra-portable X-ray machines embedded with AI for active case finding in Nigerian rural communities.

Key Points: 
  • The partnership has enabled USAID funded IHVN to deploy ultra-portable X-ray machines embedded with AI for active case finding in Nigerian rural communities.
  • Through our efforts (rural dwellers in communities with difficult terrains have been reached with TB care).
  • Our partnership with Fujifilm and Qure.ai for AI enabled TB screening is our most recent initiatives towards community outreach.
  • Together IHVN, Fujifilm and Qure.ai aim to strengthen the systems and structures for tuberculosis detection, treatment, and notification in rural Nigeria.

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Enochian, Weber, and Coinbase and Encourages Investors to Contact the Firm

Retrieved on: 
Thursday, August 11, 2022 - 2:00am

On May 25, 2022, the U.S. Department of Justice announced that Gumrukcu had been arrested and charged in a murder-for-hire conspiracy.

Key Points: 
  • On May 25, 2022, the U.S. Department of Justice announced that Gumrukcu had been arrested and charged in a murder-for-hire conspiracy.
  • On this news, Enochians stock price fell $2.17 per share, or 36.97%, to close at $3.70 per share on May 25, 2022.
  • For more information on the Coinbase class action go to: https://bespc.com/cases/COIN
    About Bragar Eagel & Squire, P.C.
  • The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country.

Gritstone Appoints Dr. Lawrence “Larry” Corey to its Board of Directors

Retrieved on: 
Wednesday, August 10, 2022 - 9:05pm

EMERYVILLE, Calif., Aug. 10, 2022 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company that aims to develop the worlds most potent vaccines, today announced the appointment of Lawrence Larry Corey, M.D., to its Board of Directors.

Key Points: 
  • EMERYVILLE, Calif., Aug. 10, 2022 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company that aims to develop the worlds most potent vaccines, today announced the appointment of Lawrence Larry Corey, M.D., to its Board of Directors.
  • Effective August 12, 2022, Dr. Corey replaces Richard Heyman, Ph.D. who stepped down as a Board Member after more than six years of service.
  • I would also like to sincerely thank Rich Heyman for his years of service on Gritstones Board of Directors, where he helped us develop and apply our novel platform technologies.
  • We are thrilled to have Larry join us to help guide continued advancement of Gritstones important clinical programs and unique scientific capabilities, said Dr. Elaine V. Jones, Chair of Gritstone bios Board of Directors.

SHAREHOLER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Enochian Biosciences Inc. of Class Action Lawsuit and Upcoming Deadline – ENOB

Retrieved on: 
Wednesday, August 10, 2022 - 6:51pm

NEW YORK, Aug. 10, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Enochian Biosciences Inc. (Enochian or the Company) (NASDAQ: ENOB) and certain of its officers and directors.

Key Points: 
  • NEW YORK, Aug. 10, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Enochian Biosciences Inc. (Enochian or the Company) (NASDAQ: ENOB) and certain of its officers and directors.
  • To discuss this action, contact Robert S. Willoughby at newaction@pomlaw.com or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext.
  • Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.

UnitedHealthcare Donates $1.5 Million to Nonprofits in California

Retrieved on: 
Wednesday, August 10, 2022 - 4:00pm

In total, UnitedHealthcare is donating $11 million in grants through its Empowering Health program across 11 states.

Key Points: 
  • In total, UnitedHealthcare is donating $11 million in grants through its Empowering Health program across 11 states.
  • Grant recipients in California include:
    Global Communities , San Diego County $320,000 to increase the availability, diversity and sustainability of breastfeeding services in San Diego.
  • Social and economic factors have a profound impact on achieving and maintaining good health, said Beth Soberg, CEO, UnitedHealthcare of California.
  • In California this includes more than $22.3 million in contributions from 2019-2021 representing its businesses, foundations and employees.

DGAP-News: Monkeypox Is Popping Up In Places It Shouldn’t But NanoViricides Says It May Have A Solution

Retrieved on: 
Wednesday, August 10, 2022 - 1:11pm

However, most of the monkeypox virus particles exit due to cell lysis, and are infectious even though not fully mature; this mode is not affected by TPOXX.

Key Points: 
  • However, most of the monkeypox virus particles exit due to cell lysis, and are infectious even though not fully mature; this mode is not affected by TPOXX.
  • It had shown effectiveness in monkeys to increase survival upon monkeypox virus infection.
  • Thus there is a clear and immediate need for rapid new drug development against monkeypox virus and potential variants.
  • During the smallpox eradication program in the late 1960s, the vaccine used to prevent smallpox also helped curb monkeypox infections.